Compare Vale SA (VALE) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vale SA vs State Street SPDR S&P Biotech ETF — how do they compare? Vale SA trades at $14.13 (market cap $59.07B), while State Street SPDR S&P Biotech ETF trades at $154.49. The key difference: Vale SA pays a 8.93% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Vale SA nearer its low. Which is the better fit depends on your goals.
| VALE | XBI | |
|---|---|---|
Market Cap | $59.07B | — |
Sector | Basic Materials | Broad Market / Factor |
52-Week High | $17.82 | $164.28 |
52-Week Low | $9.53 | $85.16 |
Enterprise Value | $75.99B | — |
Dividend Yield | 8.93% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Vale SA
Vale is the world's largest iron ore miner and one of the largest diversified miners, along with BHP and Rio Tinto. Earnings are dominated by the bulk materials division, primarily iron ore and iron ore pellets, with minor contributions from iron ore proxies, including manganese and coal. The base metals division is much smaller, primarily consisting of nickel mines and smelters with a small contribution from copper.
Read more on VALE →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
